Mustang Bio Stock Performance
| MBIO Stock | USD 0.20 0.01 4.76% |
The company secures a Beta (Market Risk) of -0.85, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Mustang Bio are expected to decrease at a much lower rate. During the bear market, Mustang Bio is likely to outperform the market. At this point, Mustang Bio has a negative expected return of -0.48%. Please make sure to verify Mustang Bio's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Mustang Bio performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Mustang Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor 1:15 | Last Split Date 2023-04-04 |
1 | Mustang Bio faces Nasdaq delisting over equity shortfall - Investing.com India | 09/13/2024 |
2 | Mustang Bio Stock Price, News Analysis - MarketBeat | 09/23/2024 |
3 | Acquisition by Litchman Manuel Md of 86206 shares of Mustang Bio at 2.91 subject to Rule 16b-3 | 09/24/2024 |
4 | Acquisition by Rosenwald Lindsay A Md of 5000 shares of Mustang Bio at 0.5164 subject to Rule 16b-3 | 10/03/2024 |
5 | Disposition of tradable shares by Rosenwald Lindsay A Md of Mustang Bio subject to Rule 16b-3 | 10/18/2024 |
6 | Insider Trading | 10/23/2024 |
7 | ARMISTICE CAPITAL, LLC Acquires New Stake in Mustang Bio Inc | 11/15/2024 |
8 | Mustang Bio files to sell 34.77M shares of common stock for holders | 11/22/2024 |
| Begin Period Cash Flow | 76.7 M |
Mustang |
Mustang Bio Relative Risk vs. Return Landscape
If you would invest 30.00 in Mustang Bio on August 28, 2024 and sell it today you would lose (10.00) from holding Mustang Bio or give up 33.33% of portfolio value over 90 days. Mustang Bio is currently does not generate positive expected returns and assumes 6.0103% risk (volatility on return distribution) over the 90 days horizon. In different words, 53% of stocks are less volatile than Mustang, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mustang Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mustang Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mustang Bio, and traders can use it to determine the average amount a Mustang Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0792
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MBIO |
Estimated Market Risk
| 6.01 actual daily | 53 53% of assets are less volatile |
Expected Return
| -0.48 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Mustang Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mustang Bio by adding Mustang Bio to a well-diversified portfolio.
Mustang Bio Fundamentals Growth
Mustang Stock prices reflect investors' perceptions of the future prospects and financial health of Mustang Bio, and Mustang Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mustang Stock performance.
| Return On Equity | -11.91 | ||||
| Return On Asset | -0.97 | ||||
| Current Valuation | 7.26 M | ||||
| Shares Outstanding | 46.93 M | ||||
| Price To Earning | (11.40) X | ||||
| Price To Book | 31.75 X | ||||
| EBITDA | (48.06 M) | ||||
| Net Income | (51.6 M) | ||||
| Cash And Equivalents | 107.37 M | ||||
| Cash Per Share | 1.01 X | ||||
| Total Debt | 2.5 M | ||||
| Debt To Equity | 0.35 % | ||||
| Current Ratio | 9.96 X | ||||
| Book Value Per Share | (0.94) X | ||||
| Cash Flow From Operations | (49.48 M) | ||||
| Earnings Per Share | (1.33) X | ||||
| Market Capitalization | 9.8 M | ||||
| Total Asset | 17.74 M | ||||
| Retained Earnings | (380.97 M) | ||||
| Working Capital | (4.03 M) | ||||
| Current Asset | 42.37 M | ||||
| Current Liabilities | 3.93 M | ||||
About Mustang Bio Performance
By examining Mustang Bio's fundamental ratios, stakeholders can obtain critical insights into Mustang Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Mustang Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.91) | (2.76) | |
| Return On Capital Employed | (21.39) | (20.32) | |
| Return On Assets | (2.91) | (2.76) | |
| Return On Equity | (419.53) | (398.55) |
Things to note about Mustang Bio performance evaluation
Checking the ongoing alerts about Mustang Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mustang Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mustang Bio generated a negative expected return over the last 90 days | |
| Mustang Bio has high historical volatility and very poor performance | |
| Mustang Bio has some characteristics of a very speculative penny stock | |
| Mustang Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (51.6 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mustang Bio currently holds about 107.37 M in cash with (49.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Mustang Bio has a frail financial position based on the latest SEC disclosures | |
| Latest headline from seekingalpha.com: Mustang Bio files to sell 34.77M shares of common stock for holders |
- Analyzing Mustang Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mustang Bio's stock is overvalued or undervalued compared to its peers.
- Examining Mustang Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mustang Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mustang Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mustang Bio's stock. These opinions can provide insight into Mustang Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.33) | Revenue Per Share (0) | Return On Assets (0.97) | Return On Equity (11.91) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.